Kim JJ, Salomon JA, Weinstein MC, Goldie SJ. Packaging health services with consideration of limited monetary and human resources: the example of a single cervical cancer screening visit. PLoS Med; in press.

Woo PPS, Kim JJ, Leung GM. What is the most cost-effective population-based cancer screening package for Hong Kong Chinese women? J Clin Oncol; in press.

Goldie SJ, Kim JJ, Myers ER. Chapter 19: Cost-effectiveness of cervical cancer screening. Vaccine 2006;24 Suppl 3:S164-70.

Garnett GP, Kim JJ, French K, Goldie SJ. Chapter 21: Modeling the impact of human papillomavirus (HPV) vaccines on cervical cancer and screening programmes. Vaccine 2006;24 Suppl 3:S178-86.

Kim JJ. Mathematical model of HPV provides insight into impacts of risk factors and vaccine. PLoS Med 2006;3:e164.

Kulansingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ. A cost-effectiveness analysis based on the ASCUS and LSIL triage study (ALTS). J Natl Cancer Inst 2006;98:92-100.

Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst 2005;97:888–95.

Kim JJ, Leung G, Woo P, Goldie SJ. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong. J Public Health 2004;26:130-137.

Goldie SJ, Kim JJ, Wright TC. Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstet Gynecol 2004;103:619-631.

Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-2390.